Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday

Aurora Cannabis (NASDAQ:ACB) is projected to release its Q4 2025 earnings data before the market opens on Wednesday, June 18th. Analysts expect Aurora Cannabis to post earnings of $0.11 per share and revenue of $88.85 million for the quarter.

Aurora Cannabis Stock Up 5.1%

Shares of NASDAQ:ACB opened at $6.15 on Tuesday. The firm has a fifty day moving average price of $5.01 and a two-hundred day moving average price of $4.73. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.30 and a quick ratio of 1.60. Aurora Cannabis has a one year low of $3.42 and a one year high of $7.20. The company has a market cap of $345.72 million, a price-to-earnings ratio of 123.02 and a beta of 1.82.

Institutional Trading of Aurora Cannabis

An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. lifted its stake in shares of Aurora Cannabis Inc. (NASDAQ:ACB) by 4.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 743,903 shares of the company’s stock after acquiring an additional 29,099 shares during the period. Goldman Sachs Group Inc. owned approximately 1.32% of Aurora Cannabis worth $3,266,000 as of its most recent SEC filing. 47.63% of the stock is currently owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.